Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone...
Leadership
Remy Luthringer Ph.D.
Executive Chairman & CEO
Frederick W. Ahlholm CPA
Senior VP, CFO & Secretary
Joseph Reilly
Senior VP & COO
William B. Boni
Vice President of Investor Relations & Corporate Communications
